New Data Supports Use Of Epidiolex In Tuberous Sclerosis Complex

By |2024-12-12T03:01:04+00:0012 December 2024|

Jazz Pharmaceuticals has shared new data to support the efficacy of Epidiolex in patients with tuberous sclerosis complex (TSC).  Research shared at the American Epilepsy Society (AES) 2024 Annual Meeting held from 6-10 December in Los Angeles, California supports the use of Epidiolex in the treatment [...]